Literature DB >> 11410108

Maximizing the success rate of minimal model insulin sensitivity measurement in humans: the importance of basal glucose levels.

I F Godsland1, C Walton.   

Abstract

Minimal model analysis of glucose and insulin concentrations in the intravenous glucose tolerance test (IVGTT) has been widely used to obtain a measure of insulin sensitivity in humans. Issues of model validity and IVGTT protocol have been explored extensively. Less attention has been paid, however, to the computer programming protocol for estimating the model parameters (programming implementation). Minimal model analysis of data from an IVGTT protocol involving a high glucose dose (0.5 g/kg) and a reduced sample schedule, employed in healthy pre- or post-menopausal women, healthy men or men with coronary heart disease or chronic heart failure (20 in each group), was undertaken according to 12 different programming implementations using a commercially available model-equation-solving program. The ability of the program to arrive at an acceptable solution to the model equations gave a success rate of between 39% and 96%, depending on the implementation. Variation in basal glucose assignment significantly affected the magnitude of estimates of insulin sensitivity. The maximum modelling success rate was achieved by introduction of an imputed glucose measurement at 360 min from the glucose injection, taking the basal glucose level as the fasting glucose concentration, and overweighting the initial glucose measurement after a delay for mixing. Use of this implementation to analyse data from a study comparing insulin sensitivities obtained using the minimal model and a euglycaemic clamp reference gave a correlation of 0.80 (P<0.001) between the two methods. Straightforward variations in programming implementation, involving appropriate assignment of the basal glucose concentration and use of an imputed glucose measurement signifying re-establishment of basal glucose levels following the IVGTT, can considerably improve modelling success rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410108

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Bayesian hierarchical methods to interpret the (13)C-octanoic acid breath test for gastric emptying.

Authors:  Leslie J C Bluck; Sarah J Jackson; Georgios Vlasakakis; Adrian Mander
Journal:  Digestion       Date:  2010-11-01       Impact factor: 3.216

2.  Backpropagation Neural Network-Based Machine Learning Model for Prediction of Blood Urea and Glucose in CKD Patients.

Authors:  Jivan Parab; Marlon Sequeira; Madhusudan Lanjewar; Caje Pinto; Gourish Naik
Journal:  IEEE J Transl Eng Health Med       Date:  2021-05-13       Impact factor: 3.316

3.  Dimensional analysis of MINMOD leads to definition of the disposition index of glucose regulation and improved simulation algorithm.

Authors:  Aparna Nittala; Soumitra Ghosh; Darko Stefanovski; Richard Bergman; Xujing Wang
Journal:  Biomed Eng Online       Date:  2006-07-14       Impact factor: 2.819

Review 4.  Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes.

Authors:  Andrea Mari; Andrea Tura; Eleonora Grespan; Roberto Bizzotto
Journal:  Front Physiol       Date:  2020-11-25       Impact factor: 4.566

5.  Dipeptidyl-Peptidase-IV Inhibitors, Imigliptin and Alogliptin, Improve Beta-Cell Function in Type 2 Diabetes.

Authors:  Xu Liu; Yang Liu; Hongzhong Liu; Haiyan Li; Jianhong Yang; Pei Hu; Xinhua Xiao; Dongyang Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-20       Impact factor: 5.555

6.  Non-invasive continuous-time glucose monitoring system using a chipless printable sensor based on split ring microwave resonators.

Authors:  Masoud Baghelani; Zahra Abbasi; Mojgan Daneshmand; Peter E Light
Journal:  Sci Rep       Date:  2020-07-31       Impact factor: 4.379

Review 7.  Adapting Protocols or Models for Use in Insulin-Requiring Diabetes and Islet Transplant Recipients.

Authors:  Glenn M Ward; Jacqueline M Walters; Judith L Gooley; Raymond C Boston
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.